Survival of HIV/HCV Co-Infected Patients Before Introduction of HCV Direct Acting Antivirals (DAA)

Scientific Reports - United Kingdom
doi 10.1038/s41598-019-48756-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Editorial: Direct Acting Antivirals - Not the Be-All and End-All in HIV/HCV Co-Infection. Authors' Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Letter: HBV/HCV Coinfection in the Era of Direct-Acting Antivirals

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Efficacy and Safety of Hepatitis C Direct-Acting Protease Inhibitors (DAA-PI ) in Real Life in HIV-HCV Coinfected Patients

BMC Infectious Diseases
Infectious Diseases
2014English

Correction of Metabolic Disorders in Patients Co-Infected With HIV/HCV

ScienceRise
2015English

Imaging Findings of Hepatocellular Carcinoma That Developed After HCV Eradication With Direct-Acting Antivirals

Acta Hepatologica Japonica
Hepatology
2019English

Changes of Body Immunity and Inflammatory Response in HIV/HCV Co-Infected Patients

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2018English

Editorial: Good News to Patients With Thalassaemia-HCV Clearance Made Easy With Direct Acting Antivirals. Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Genetic Barrier to Direct Acting Antivirals in HCV Sequences Deposited in the European Databank

PLoS ONE
Multidisciplinary
2016English

Benefit of Direct-Acting Antiviral Therapy for Hepatitis C Virus (HCV) in Monoinfected and HIV-HCV Coinfected Patients With Mixed Cryoglobulinemia

Clinical Microbiology and Infection
MedicineInfectious DiseasesMicrobiology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy